A Randomized Open Blind Control Study Assessing Clopidogrel Resistance in Iranian Patients Undergoing Percutaneous Coronary Intervention in Rajaie Heart Center

authors:

avatar Hosein ali Basiri 1 , * , avatar Bahram Fariborz Farsad 1 , **

Iran
Corresponding Authors:

how to cite: Basiri H A , Farsad B F. A Randomized Open Blind Control Study Assessing Clopidogrel Resistance in Iranian Patients Undergoing Percutaneous Coronary Intervention in Rajaie Heart Center. Multidiscip Cardio Annal. 2012;4(2):e8771.

Abstract

The prevalence of response variability to clopidogrel in Iranian patients undergoing
elective percutaneous coronary intervention (PCI) with stenting, impleta has not been
fully investigated. We evaluated clopidogrel antiplatelet effects of 300 mg versus a 450
mg in open blind randomized clinical trial in a referral teaching hospital in Iran.

Fulltext

Full Text Available is PDF

References

  • 1.

    Full Text Available is PDF

© 2012, Multidisciplinary Cardiovascular Annals. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.